• No results found

University of Groningen Circulating tumor cells and the micro-environment in non-small cell lung cancer Tamminga, Menno

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Circulating tumor cells and the micro-environment in non-small cell lung cancer Tamminga, Menno"

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Tamminga, Menno

DOI:

10.33612/diss.132713141

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Tamminga, M. (2020). Circulating tumor cells and the micro-environment in non-small cell lung cancer.

University of Groningen. https://doi.org/10.33612/diss.132713141

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Circulating tumor cells and the micro-environment

in non-small cell lung cancer

(3)

Printing:

Ridderprint | www.ridderprint.nl

Copyright © 2020 Menno Tamminga

All rights reserved. No part of this thesis may be reproduced, stored or

trans-mitted in any way or by any means without the prior permission of the author, or

when applicable, of the publishers of the scientific papers.

(4)

Circulating tumor cells and the micro-environment

in non-small cell lung cancer

Proefschrift

ter verkrijging van de graad van doctor aan de

Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. C. Wijmenga

en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op

woensdag 30 september 2020 om 11.00 uur

door

Menno Tamminga

geboren op 19 mei 1989

te Hoogeveen

(5)

Prof. dr. S. De Jong

Prof. dr. G.A. Huls

Prof. dr. N.H. Stoecklein

(6)

Content

Chapter 1 Introduction 7

Chapter 2 Single tube liquid biopsy for advanced non-small cell lung cancer International journal of cancer

31 Chapter 3 Circulating tumor cells in lung cancer are prognostic and predictive

for worse tumor response in both targeted- and chemotherapy Translational lung cancer

61

Chapter 4 Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors

Journal for immunotherapy of cancer

81

Chapter 5 Release of circulating tumor cells during surgery for non-small cell lung cancer: are they what they appear to be?

Clinical cancer research

105

Chapter 6 Diagnostic leukapheresis increases circulating tumor cell yield in non-small cell lung cancer patients.

Submitted

135

Chapter 7 Filtration by microsieves of leukapheresis product for the detection of circulating tumor cells in non-small cell lung cancer patients. Translational lung cancer

167

Chapter 8 Detection of circulating tumor cells in the diagnostic leukapheresis product of non-small cell lung cancer patients; CellSearch® and ISET® compared.

Cancers (Basel)

187

Chapter 9 Molecular loci distinguish lung cancer subtypes and regulation of immune genes

Lung cancer

215

Chapter 10 Immune microenvironment composition in non-small cell lung cancer and its association with survival

Clinical & translational immunology

251

Chapter 11 Discussion 287

Appendix English summary 308

Nederlandse samenvatting 314

Acknowledgements 320

Curriculum Vitae 325

(7)

Referenties

GERELATEERDE DOCUMENTEN

The question remains whether alterations in HPA axis are the result of abnormal pain perception or that CP can be seen as a consequence of HPA axis dysfunction (Adler &

Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors. Circulating Tumor Cells Identify

PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system.

We studied the relation between overall survival (OS) and the presence of four cancer biomarkers from a single blood draw in advanced NSCLC patients: EpCAM high circulating

In this study we showed that the presence of CTC before therapy is a risk factor for worse tumor response rates and survival in advanced non-small cell lung cancer, irrespective

Percentage of advanced non-small cell lung cancer (NSCLC) patients with an early response (partial and complete response according to the revised response evaluation criteria in

For patients undergoing an open thoracotomy, 7.5 mL of blood was drawn from the radial artery at the start of surgery (baseline, T0), followed by blood draws from both the

Microsieves for the detection of circulating tumor cells in leukapheresis product in non-small cell lung cancer patients.. Chapter